Aurobindo Pharma informs about acquisition

07 Nov 2020 Evaluate

With refer to earlier letter dated October 17, 2020 informing about entering into a share purchase agreement to acquire 100% equity share capital of MViyeS Pharma Ventures (MViyeS), Aurobindo Pharma has informed that the aforesaid acquisition has been completed on November 6, 2020. Before acquisition, MViyeS was holding 32.18% shareholding in Eugia Pharma Specialities, a joint venture company in which the Company is holding the balance 67.82%. Now, both Eugia Pharma Specialities and MViyeS Pharma Ventures have become 100% subsidiaries of the Company.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1303.20 -10.55 (-0.80%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×